Lv1
48 积分 2025-04-13 加入
Integrative analysis of tertiary lymphoid structures and immune infiltration in ccRCC microenvironment revealed their clinical significances: a multicenter cohort study
1个月前
已完结
Nivolumab plus ipilimumab for potentially resectable hepatocellular carcinoma: Long-term efficacy and biomarker exploration
1个月前
已完结
PD-1 blockade unleashes local hepatitis B virus-related B cell response inhibiting hepatocellular carcinoma
1个月前
已完结
Refining risk stratification in hepatocellular carcinoma by integrating tertiary lymphoid structures and microvascular invasion: a multicenter retrospective study
1个月前
已完结
Spatial architecture of tertiary lymphoid structures represents an independent prognostic dimension in hepatocellular carcinoma
1个月前
已完结
Humoral IgG1 responses to tumor antigens underpin clinical outcomes in immune checkpoint blockade
1个月前
已完结
Avidity in antibody effector functions and biotherapeutic drug design
2个月前
已完结
AID targeting in antibody diversity
2个月前
已完结
Pan-cancer spatial atlas of tertiary lymphoid structures
2个月前
已完结
Class-switch recombination: interplay of transcription, DNA deamination and DNA repair
2个月前
已完结
皖公网安备34019202002308
